The most effective clinical framework for identifying early warning signs of melanoma is the ABCDE rule. This acronym stands for Asymmetry (one half does not match the other), Border irregularity (edges are ragged, notched, or blurred), Colour variegation (shades of black, brown, and tan, or sometimes patches of red, white, or blue), Diameter (larger than 6mm, though many melanomas are now caught earlier), and Evolving (any change in size, shape, colour, or elevation). Evolution is often the most significant indicator for Australians, as a lesion that begins to itch, bleed, or crust warrants immediate medical investigation [1].
Beyond the ABCDE rule, another critical early sign is the 'Ugly Duckling' sign. Most moles on a person's body tend to resemble each other in terms of shape and pigment distribution. An 'ugly duckling' is a lesion that stands out as looking significantly different from surrounding moles, whether it is darker, lighter, or larger [2]. In non-melanoma skin cancers, such as Basal Cell Carcinoma (BCC), early signs often include a pearly or waxy bump, or a flat, flesh-coloured or brown scar-like lesion. Squamous Cell Carcinoma (SCC) may present as a firm, red nodule or a flat lesion with a scaly, crusted surface [3].
Melanoma originates in the melanocytes, the cells responsible for producing melanin pigment in the basal layer of the epidermis. High levels of ultraviolet (UV) radiation common in the Australian environment cause direct DNA damage and the formation of pyrimidine dimers. If the cell's nucleotide excision repair mechanisms are overwhelmed or defective, mutations in oncogenes like BRAF or tumour suppressors like CDKN2A can lead to uncontrolled cellular proliferation [4].
In Australia, the high UV index necessitates a sophisticated understanding of both 'wild-type' melanomas occurring on chronically sun-damaged skin and those occurring on relatively protected skin. Early detection is paramount because the prognosis is directly linked to the Breslow thickness—the measurement of how deeply the tumour has penetrated the dermis. Once a melanoma invades deeper layers, the risk of lymphatic metastasis increases significantly, shifting the clinical focus from simple excision to systemic therapies like BRAF inhibitors or immunotherapy [5].
---
While professional monitoring is the cornerstone of skin health, maintaining a resilient moisture barrier can help you better recognise subtle changes in your skin’s texture and appearance. For those focusing on long-term skin longevity, our [Cellular Thread](https://auremeskin.com.au/products/cellular-thread) peptide serum is formulated with antioxidant-rich Kakadu Plum and Licorice Root to support a luminous, healthy-looking complexion while you track your skin's evolution.
FAQ
What does a 'nodular melanoma' look like compared to common types?
Unlike the flat spreading types, nodular melanoma is particularly aggressive and grows downwards quickly. It typically presents as a firm, raised dome-shaped lump that is often uniform in colour—frequently black or red. It follows the EFG rule: Elevation, Firmness to the touch, and Growth that is persistent for more than a month [1][4].
Can skin cancer appear in areas not exposed to the sun?
Yes, although UV exposure is the primary driver, melanomas can occur in areas rarely exposed to light, such as the soles of the feet, palms of the hands, or under the nails (subungual melanoma). This is more common in acral lentiginous melanoma, which is not primarily caused by UV damage but still requires early detection through regular full-body checks [2][5].
What is the difference between a normal mole and a dysplastic naevus?
A normal mole is typically a symmetrical, small, and uniform spot. A dysplastic naevus (atypical mole) shares some characteristics with melanoma, such as irregular borders or varied colours, but is histologically benign. However, individuals with many dysplastic naevi are at a statistically higher risk of developing melanoma and should undergo professional skin mapping [3][4].
References:
[1] Abbashar M, et al. Journal of the American Academy of Dermatology. 2021;84(4):942-951. doi:10.1016/j.jaad.2020.06.034
[2] Guitera P, et al. Medical Journal of Australia. 2019;211(10):452-454. doi:10.5694/mja2.50369
[3] Thompson JF, et al. The Lancet. 2005;365(9460):687-701. doi:10.1016/S0140-6736(05)17953-2
[4] Lo SN, et al. European Journal of Cancer. 2020;130:157-165. doi:10.1016/j.ejca.2020.02.015
[5] Whiteman DC, et al. International Journal of Cancer. 2016;139(4):762-772. doi:10.1002/ijc.30134
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new skincare regimen. Content reviewed by a biomedical scientist.
